In a report released today, Matt Miksic from Barclays maintained a Sell rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

Zimmer Biomet Holdings Inc is a global leader in medical technology, specializing in designing and manufacturing orthopedic reconstructive products, including knee and hip replacements.

Shares of Zimmer Biomet Holdings Inc. ZBH dropped 0.98% to $108.40 Tuesday, on what proved to be an all-around grim trading ...

Analysts have recently evaluated Zimmer Biomet Holdings and provided 12-month price targets. The average target is $121.76, accompanied by a high estimate of $145.00 and a low estimate of $107.00.

WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who ...

WARSAW, Ind., Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global ...